MENU

SLDB Solid Biosciences Forecast, Technical & Fundamental Analysis

Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases... Show more

Industry: #Biotechnology
SLDB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
SLDB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

SLDB is expected to report earnings to rise 9.08% to -41 cents per share on November 11

Solid Biosciences SLDB Stock Earnings Reports
Q3'26
Est.
$-0.41
Q2'26
Beat
by $0.07
Q1'26
Beat
by $0.13
Q4'25
Beat
by $0.09
Q3'25
Beat
by $0.17
The last earnings report on August 06 showed earnings per share of -37 cents, beating the estimate of -44 cents. With 371.70K shares outstanding, the current market capitalization sits at 780.60M.
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAUC20.560.93
+4.74%
Allied Gold Corp
RVTY154.182.02
+1.33%
Revvity
VRA5.140.06
+1.18%
Vera Bradley
HIFS288.33-2.28
-0.78%
Hingham Institution for Savings
SYNX0.85-0.01
-0.95%
Silynxcom Ltd

SLDB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SLDB has been loosely correlated with EDIT. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if SLDB jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLDB
1D Price
Change %
SLDB100%
+0.73%
EDIT - SLDB
59%
Loosely correlated
+2.11%
CRBU - SLDB
56%
Loosely correlated
-4.36%
RCKT - SLDB
54%
Loosely correlated
-2.66%
IMTX - SLDB
53%
Loosely correlated
+0.81%
BEAM - SLDB
53%
Loosely correlated
+4.47%
More
A.I. Advisor
published General Information

General Information

a developer of novel gene therapy platform for advancing disease

Industry Biotechnology

Industry
Biotechnology
Address
500 Rutherford Avenue
Phone
+1 617 337-4680
Employees
121
Web
https://www.solidbio.com